top of page
Writer's pictureLester Davids

PFIZER Inc. (PFE): Is This Pharma Stock Worth A Shot? - Tuesday, 30 July 2024

Updated: Aug 5

  • Published Pre-Market U.S.

  • Last Close: $30.72 (Pre-Market Price: $30.41)

  • It is known that 'from false moves comes fast moves'

  • The share reclaimed multi-year support extending back to 2013

  • It has developed a multi-month base and has started to break to the upside.

  • Now, trading back above the 21-week exponential moving average.

  • Currently trading in a high bullish momentum regime (approaching overbought)

  • Look to buy on pullbacks targeting +$33.50 on the upside

  • Stop-loss is a close below the 21-week.

  • Short to medium term view.



Lester Davids

Analyst: Unum Capital


4 views0 comments

Comments


bottom of page